1-5 of 5
Andrew M. Yeager, M.D.
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

A Relapse Risk Score to Predict Acute Myeloid Leukemia Relapse After Nonmyeloablative Allogeneic Hematopoietic Cell Transplantation Based on Pre-Transplant Variables.

Boglarka Gyurkocza, M.D., Rainer Storb, M.D., Barry E. Storer, Ph., D., Thomas Chauncey, MD, Thoralf Lange, M.D., Ginna G. Laport, MD, Amelia Langston, M.D., Michael A. Pulsipher, M.D., Christopher Bredeson, M.D., Richard Maziarz, M.D., Benedetto Bruno, M.D., Finn Petersen, M.D., Michael Maris, M.D., Edward Agura, M.D., Andrew M. Yeager, M.D., Wolfgang A. Bethge, M.D., Firoozeh Sahebi, M.D., Frederick R. Appelbaum, M.D., David G. Maloney, M.D., Elihu H. Estey, M.D., Brenda M. Sandmaier, MD
Journal: Blood
Blood (2010) 116 (21): 3450.
https://doi.org/10.1182/blood.V116.21.3450.3450
Published: 2010
Journal Articles

Treatment of Relapsed or Refractory Non-Hodgkin’s Lymphoma (NHL) or Hodgkin’s Disease (HD) with High-Dose Chemotherapy and Autologous Hematopoietic Stem Cell Transplantation (HSCT) Using a Novel Mitoxantrone-Containing Preparative Regimen.

Leslie Andritsos, MD, Wendy Suhre, Mark Nahirny, Ellen Chase, Michael Carroll, M.D., Jennifer Christian, Thomas P. Miller, MD, Andrew M. Yeager, M.D.
Journal: Blood
Blood (2006) 108 (11): 5264.
https://doi.org/10.1182/blood.V108.11.5264.5264
Published: 2006
Journal Articles

Outpatient High-Dose Chemotherapy and Autologous Hematopoietic Cell Transplantation for Multiple Myeloma Is Associated with a Low Infection Safety Profile.

Mounzer E. Agha, M.D., Andrew M. Yeager, M.D., Carol Evans, M.D., Nikol Borkowski, P.A.-C., Anne Marie Scekeres, R.N., Sarah Miller, P.A.-C., Cheryl Tompkins, C.R.N.P., Rowena Schwartz, Pharm.D., Albert D. Donnenberg, Ph.D., Jeffrey Shogan, M.D.
Journal: Blood
Blood (2004) 104 (11): 5070.
https://doi.org/10.1182/blood.V104.11.5070.5070
Published: 2004
Journal Articles

Infection Is the Major Cause of Mortality after Nonmyeloablative Unrelated Bone Marrow Transplantation with Alemtuzumab, Fludarabine and Melphalan.

Michael P. Carroll, M.D., Diane BuchBarker, M.D., Rowena Schwartz, Pharm.D., Mounzer E. Agha, M.D., Cheryl Tompkins, C.R.N.P., Kristen Baileys, C.R.N.P., Kathleen O’Connell, R.N., Albert D. Donnenberg, Ph.D., Andrew M. Yeager, M.D.
Journal: Blood
Blood (2004) 104 (11): 5165.
https://doi.org/10.1182/blood.V104.11.5165.5165
Published: 2004
Journal Articles

Intensive Immunosuppression Plus T-Cell Depleted Autologous Peripheral Blood Stem Cell Transplantation for Systemic Sclerosis.

Diane BuchBarker, M.D., Albert D. Donnenberg, Ph.D., Thomas A. Medsger, M.D., Michael P. Carroll, M.D., Deborah L. Griffin, B.A., Carol Blair, R.N., Darrell Lis, R.N., M.S.N., Andrew M. Yeager, M.D.
Journal: Blood
Blood (2004) 104 (11): 5205.
https://doi.org/10.1182/blood.V104.11.5205.5205
Published: 2004